The Roche antibody test helps determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV2. Anti-SARS-CoV-2 antibody test accurately identifies COVID-19 antibodies in the blood 100% of the time, 14 days post-infection.
The test is uniquely designed to identify mature antibodies developed late in the immune response, significantly reducing the chance of a false-positive result. It provides 99.8 percent specificity, which is greater than previously available antibody tests. The specificity is crucial to determine reliably if a person has been exposed to the virus and has developed antibodies.
Features and Benefits of Roche’s Antibody test
About Antibody Testing
An antibody test also called a serology test, is used to determine whether a person might have gained immunity against a pathogen or not. The human body makes antibodies in response to many illnesses. In the current situation of the COVID-19 pandemic, antibody tests need to be able to specifically detect antibodies against SARS-CoV-2 with no cross-reactivity to other similar coronaviruses, which could generate a false-positive result and thus wrongly indicate potential immunity. A false-positive result happens when a person receives a positive test result when they should have received a negative result. False positives are particularly critical when we do not know how many people in a given population have had COVID-19.
About the Elecsys® Anti-SARS-CoV-2 test
The Elecsys® Anti-SARS-CoV-2 test, can detect antibodies to the new coronavirus causing COVID-19, which could signal whether a person has already been infected and potentially developed immunity to the virus. Based on the measurement of a total of 5272 samples, the Elecsys® Anti-SARS-CoV-2 assay has 99.8% specificity and shows no cross-reactivity to the common cold, HIV and other coronaviruses. This means it can lower the chance of false positives due to the detection of similar antibodies that may be present in an individual. Elecsys® Anti-SARS-CoV-2 detected antibodies with 100% sensitivity in samples taken 14 days after a PCR-confirmed infection.
More information for healthcare providers, patients and the general public is available at diagnostics.roche.com. Technical information about the test is available at Elecsys® Anti-SARS-CoV-2 test.
Elecsys® Anti-SARS-CoV-2 Tests Are Now Here
The Medical Group of South Florida is proud to now offer the Roche Antibody tests. This test provides reliable and high-quality results for clinical decision-making for patients with suspected COVID-19 (coronavirus) infection.
To ensure we will have a test for you please call 561.622.6111 to schedule your appointment or book through our website here: https://mgsfl.com/book-an-appointment/